Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DR26FNL4Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) to support federal medical procurement needs. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of November 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the comprehensive pharmaceutical support vehicle for federal military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contracting presence as a critical vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains through open competition. This delivery order for Vyndamax, a specialty medication, reflects the company's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through the DLA's pharmaceutical prime vendor program, which manages medical supply chains for defense and military health operations globally.
Quick answers
Who was awarded contract SPE2DR26FNL4Q?
SPE2DR26FNL4Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FNL4Q worth?
The government has obligated $14,593 on SPE2DR26FNL4Q.
Is contract SPE2DR26FNL4Q an order under another contract?
Yes. SPE2DR26FNL4Q is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNL4Q competed?
The extent of competition for SPE2DR26FNL4Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award